Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report

INTRODUCTION: There are limited treatment options for people with schizophrenia with cytochrome P450 2D6 ultrarapid metabolizer status who do not respond to amisulpride. Furthermore, the literature does not provide evidence-based guidelines for this particular constellation. CASE PRESENTATION: We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahr, Maximilian, Gastl, Regina, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Freudenmann, Roland W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298719/
https://www.ncbi.nlm.nih.gov/pubmed/22309430
http://dx.doi.org/10.1186/1752-1947-6-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298719/
https://www.ncbi.nlm.nih.gov/pubmed/22309430
http://dx.doi.org/10.1186/1752-1947-6-49

Ejemplares similares